(Q41555018)

3 October 2017

Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels (English)

1 reference

3 October 2017

Effects of the combination of tripelennamine and Pentazocine at the behavioral and molecular levels (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

19 September 2023

author name string

H. E. Shannon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6294681

19 September 2023

T. P. Su

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6294681

19 September 2023

language of work or name

English

0 references

publication date

1 October 1982

1 reference

full work available at URL

3 October 2017

https://api.elsevier.com/content/article/PII:0091305782903628?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

https://api.elsevier.com/content/article/PII:0091305782903628?httpAccept=text/plain

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Pharmacology, Biochemistry and Behavior

19 September 2023

published in

1 reference

3 October 2017

17

1 reference

3 October 2017

4

1 reference

3 October 2017

789-795

1 reference

Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects

3 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Abuse and Pulmonary Complications of Injecting Pentazocine and Tripelennamine Tablets

19 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

On the ability of narcotic antagonists to produce the narcotic cue

19 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Pentazocine, cyclazocine, and nalorphine as discriminative stimuli

19 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics

19 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships

19 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

The effects of adrenaline, noradrenaline and isoprenaline on inhibitory α- and β-adrenoceptors in the longitudinal muscle of the guinea-pig ileum

19 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone

19 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Characteristics and Sequelae of Paregoric Abuse

19 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Self-administration of tripelennamine by a narcotic addict

19 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Investigation of narcotics and antitussives using drug discrimination techniques

19 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Opiate Receptor: Demonstration in Nervous Tissue

19 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Discriminative effects of cyclazocine in the squirrel monkey

19 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Morphine-like stimulus effects in the monkey: opioids with antagonist properties.

19 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Evaluation of the discriminative effects of morphine in the rat

19 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Further evaluation of the discriminative effects of morphine in the rat

19 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Morphine training dose: A determinant of stimulus generalization to narcotic antagonists in the rat

19 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

T's and blues. Abuse of pentazocine and tripelennamine

19 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Patterns of pulmonary fibrosis as related to pulmonary function

19 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Pulmonary Angiothrombosis Caused by "Blue Velvet" Addiction

19 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex

19 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Cardiovascular responses to pentazocine and tripelennamine in anesthetized rats.

19 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Potentiation of lethality in mice by combinations of pentazocine and tripelennamine

19 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’)

19 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

Narcotic drug discriminations by rhesus monkeys and pigeons

19 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0091-3057(82)90362-8

19 September 2023

Identifiers

1 reference

3 October 2017

1 reference